PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Interventional Oncology Technology Market in Europe to Benefit from Expanded Awareness & Patient-friendly Treatment Procedures Finds Frost & Sullivan - The interventional oncology technology market in Europe is in its growth stage. Increased awareness about cancer and the different kinds of interventional oncology technologies available to treat this disease are spurring market prospects
Interventional Oncology Technology Market in Europe to Benefit from Expanded Awareness & Patient-friendly Treatment Procedures Finds Frost & Sullivan

 

NewswireToday - /newswire/ - London, United Kingdom, 2011/04/04 - The interventional oncology technology market in Europe is in its growth stage. Increased awareness about cancer and the different kinds of interventional oncology technologies available to treat this disease are spurring market prospects.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The focus is on easy-to-use, patient-friendly and minimally invasive technology devices.

New analysis from Frost & Sullivan (patientmonitoring.frost.com), European Market for Interventional Oncology Technology, estimates the market to reach $51.7 million in 2016. This research covers the following markets: radio frequency ablation (RFA), microwave ablation (MWA), hi frequency focussed ultrasound (HIFU) and cryoablation.

"The most important driver in the market is the requirement of easy-to-use and patient-friendly minimally invasive or non–invasive devices that support enhanced cancer therapy management," notes Frost & Sullivan Senior Research Analyst Akanksha Joshi. "The increasing demand for patient-friendly, easy-to-operate and well designed equipment at affordable prices will boost the sales of technologically advanced products."

The rapid greying of western Europe has been accompanied by the increased occurrence of diseases like cancer. This has further underlined the need for methods that can detect and treat cancer at the earliest, thus saving patients' lives.

"This has motivated the demand for patient-friendly minimally invasive technologies to cure cancer," says Joshi. "There is an urgent demand for novel, low-cost technologies that reduce the duration of hospitalization, while offering patients rapid and robust treatment for cancer."

However, the low reimbursement rate for interventional oncology technology as compared to the traditional form of treating cancer – surgery – has led to a decline in the number of patients opting for these advanced treatment methods.

The traditional method of using surgery as a mode of treatment for cancer is available to patients at a much lower rate and is reimbursed across Europe. At present, the medical community also considers it the most trusted method.

On the other hand, using interventional oncology technology makes the treatment extremely expensive, thus hindering their uptake.

"Collaboration with established local companies would help the manufacturers of niche technologies to provide effective services, while maintaining profit margins," advises Joshi. "To succeed, manufacturers must provide innovative, accurate and reliable patient friendly devices."

If you are interested in more information about this study, please send an email with your contact details to Chiara Carella, Corporate Communications, at chiara.carella[.]frost.com.

European Market for Interventional Oncology Technology is part of the Patient Monitoring Growth Partnership Services programme, which also includes research in the following markets: European Market for Ventilation and Airway Management Devices, European Markets for Disease Management and European Market for Multiparameter mid range Patient Monitors. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents.

European Market for Interventional Oncology Technology / M6CB

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Interventional Oncology Technology Market in Europe to Benefit from Expanded Awareness & Patient-friendly Treatment Procedures Finds Frost & Sullivan

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan |
Publisher Contact: Chiara Carella 
+44 (0) 20 7343 8314 chiara.carella[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Sparta Systems Broadens Partnership with TrackWise Implementation Specialist Equality Systems
Thales Launches the Pixium Portable 3543 DR Wifi Enabled Flat Panel Detector
GE Healthcare Showcases Industry-first Technologies and Digital Solutions, Focused on Improving Outcomes, At RSNA 2016
Agfa and LCsys Team Up to Launch ABSOLUT-ID, Their Turnkey Integrated Solution for the Production of High Security ID Cards
ZOLL Technology for Improving CPR Quality to be Showcased at American Heart Association Annual Conference
AccuVein to Exhibit Leading Vein Visualization Technology at American Society for Dermatologic Surgery Annual Meeting
US Biomedical Textiles Transform Implant Device Technology by Aligning to Changes in Patient Preference Finds Frost & Sullivan
Frost & Sullivan Commends Influence Health for Constantly Evolving its Patient Engagement Products to Accelerate Market Transformation
Frost & Sullivan Awards Carestream Top Honors for OnSight 3D Extremity System
Sparta Systems Launches the Next-Generation Cloud Solution Stratas QMS
Koning Wins Accolades from Frost & Sullivan for the Impressive Innovation Behind its Groundbreaking KBCT Breast Imaging Device
Frost & Sullivan Awards ResMed for Developing S+ Advanced Sleep Tracking System
Sparta Systems Becomes First Quality Management Solutions Provider to Achieve EU-U.S. Privacy Shield Compliance
ZOLL Expands the Rescuer Experience at EMS World Expo
Agfa and GPMI Sign Distribution Agreement for Agfa’s Synthetic Paper Synaps

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)